Literature DB >> 387936

Chloramphenicol disposition in infants and children.

C A Friedman, F C Lovejoy, A L Smith.   

Abstract

We studied the pharmacokinetics of chloramphenicol following its intravenous administration as the sodium succinate ester to 54 infants and children. The mean "apparent t 1/2" of chloramphenicol clearance from the plasma was 5.94 hours (range 0.87 to 17.8 hours). The t 1/2 of patients who weighed less than 10 kg was significantly longer than that of those who weighed more than 10 kg (9.02 vs 4.55 hours; P less than 0.0001). There was a discrepancy between the plasma levels of chloramphenicol and total aromatic nitro compounds in four patients; these compounds were cleared at different rates. Repeated dosing (eight to 30 doses) did not produce a consistent effect on the t 1/2. The CSF concentrations of chloramphenicol in 13 patients were 67% (range 45 to 99%) of the simultaneous serum concentrations. We conclude that the marked individual variation in chloramphenicol pharmacokinetics in infants and children requires monitoring of blood concentrations during therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387936     DOI: 10.1016/s0022-3476(79)80315-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Sepsis in the newborn.

Authors:  Geeta Gathwala
Journal:  Indian J Pediatr       Date:  2002-11       Impact factor: 1.967

2.  Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.

Authors:  Pablo Gustavo Scapellato; Cecilia Ormazabal; José Luis Scapellato; Edgardo Gabriel Bottaro
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Current antibiotic usage, I: Penicillins, cephalosporins and chloramphenicol.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

4.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

Review 5.  Intravenous infusion conditions. Implications for pharmacokinetic monitoring.

Authors:  M C Nahata
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

6.  Chloramphenicol therapy in the neonate.

Authors:  V K Paul
Journal:  Indian J Pediatr       Date:  1983 Jul-Aug       Impact factor: 1.967

7.  Rapid estimation of chloramphenicol clearance in infants and children.

Authors:  J R Koup; C M Sack; A L Smith; N N Neely; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 9.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.